Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort BXiuning Le, Paul K. Paik, Carlos Cabrera Galvez et al.|Cell Reports Medicine|2023Cited by 18
Clinical response to tepotinib according to circulating tumor (ct) DNA biomarkers in patients with advanced NSCLC with high-level <i>MET</i> amplification (<i>MET</i>amp) detected by liquid biopsy (LBx).Xiuning Le, Paul K. Paik, Luis Paz‐Ares et al.|Journal of Clinical Oncology|2022Cited by 13